What VCs Won't Let You Give Up to Pharma
This article was originally published in Start Up
Executive Summary
A VC will only object to deal structures which cap the upside for investors--a specific limited price, for example, in return for successfully developing an asset. If the deal leaves a residual element of upside, it could be just fine, even if it seems to take rights to an entire pipeline.